Irwin R. Merkatz - Concepedia

Author

Irwin R. Merkatz

Also Known As

I MERKATZ, I Merkatz, I R Merkatz, I. MERKATZ, I. Merkatz, I. R. MERKATZ, I. R. Merkatz, I.R Merkatz, I.R. Merkatz, IRWIN MERKATZ

172

Publications

6.2K

Citations

H-Index

169

Concepts

All Affiliations

Albert Einstein College of Medicine Case Western Reserve University Cornell University Montefiore Medical Center Yeshiva University

About

Irwin R. Merkatz is an author at Albert Einstein College of Medicine specializing in medicine, maternal health, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	34	62	4.5K
2	Health Sciences	7	7	301
3	Nursing	5	5	292
4	Education	2	2	239
5	Engineering	1	1	35

Irwin R. Merkatz

Publications

5.7K

Citations

H-Index

Page 1

	Year	Citations
An association between low maternal serum α-fetoprotein and fetal chromosomal abnormalities Irwin R. Merkatz, Harold M. Nitowsky, James N. Macri, American Journal of Obstetrics and Gynecology GeneticsFetal Chromosomal AbnormalitiesReproductive HealthGenetic EpidemiologyGynecology	1984	739
First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-based screening study (The FASTER Trial) Lorraine Dugoff, John C. Hobbins, Fergal D. Malone, American Journal of Obstetrics and Gynecology Nuchal TranslucencyReproductive HealthGynecologyMaternal HealthPregnancy	2004	617
Quad Screen as a Predictor of Adverse Pregnancy Outcome Lorraine Dugoff, John C. Hobbins, Fergal D. Malone, Obstetrics and Gynecology	2005	237
Research agenda for preterm birth: Recommendations from the March of Dimes Nancy Green, Karla Damus, Joe Leigh Simpson, American Journal of Obstetrics and Gynecology Research AgendaPrenatal DevelopmentReproductive HealthPediatricsGynecology	2005	208
The Low-Birth-Weight Infant — Evolution of a Changing Outlook Maureen Hack, Avroy A. Fanaroff, Irwin R. Merkatz New England Journal of Medicine NeonatologyImproved SurvivalMaternity ServiceChanging OutlookPrenatal Care	1979	169
Ritodrine hydrochloride: a betamimetic agent for use in preterm labor. II. Evidence of efficacy. Irwin R. Merkatz, John B. Peter, Tom P. Barden PubMed GynecologyRitodrine HydrochloridePreterm Birth PreventionPharmacotherapyObstetrics	1980	136
Methods to Encourage the Use of Antenatal Corticosteroid Therapy for Fetal Maturation Laura C. Leviton, Robert L. Goldenberg, C. Suzanne Baker, JAMA Fetal MaturationReproductive SciencesUsual DisseminationReproductive HealthFetal Medicine	1999	131
PRENATAL DIAGNOSIS OF CONGENITAL ADRENAL HYPERPLASIA (21-HYDROXYLASE DEFICIENCY) BY HLA TYPING M S Pollack, L S Levine, Songya Pang, The Lancet Developmental AnomalyAdrenal GlandBy Hla TypingMedicineInherited Metabolic Disease	1979	128
Amniotic Fluid Concentrations of Δ5 and Δ4 Steroids in Fetuses with Congenital Adrenal Hyperplasia due to 21 Hydroxylase Deficiency and in Anencephalic Fetuses* Songya Pang, L S Levine, Lars L. Cederqvist, The Journal of Clinical Endocrinology & Metabolism Amniotic Fluidδ4 SteroidsMale FetusFetal MedicineGynecology	1980	118
Ritodrine hydrochloride: a betamimetic agent for use in preterm labor. I. pharmacology, clinical history, administration, side effects, and safety. Tom P. Barden, John B. Peter, Irwin R. Merkatz PubMed Hormonal ContraceptiveGynecologyRitodrine HydrochloridePreterm Birth PreventionUnited States	1980	115

Page 1